Shanghai Rendu EBITDA vs. Market Capitalization
| 688193 Stock | 42.38 0.54 1.26% |
EBITDA | First Reported 2010-12-31 | Previous Quarter 48 M | Current Value 57.3 M | Quarterly Volatility 27.8 M |
For Shanghai Rendu profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Shanghai Rendu to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Shanghai Rendu Biotechnology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Shanghai Rendu's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Shanghai Rendu Biotechnology over time as well as its relative position and ranking within its peers.
Shanghai |
Shanghai Rendu Biote Market Capitalization vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Shanghai Rendu's current stock value. Our valuation model uses many indicators to compare Shanghai Rendu value to that of its competitors to determine the firm's financial worth. Shanghai Rendu Biotechnology is number one stock in ebitda category among its peers. It also is number one stock in market capitalization category among its peers creating about 598.13 of Market Capitalization per EBITDA. At present, Shanghai Rendu's EBITDA is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all model that can be used if you cannot value Shanghai Rendu by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Shanghai Rendu's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Shanghai Market Capitalization vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Shanghai Rendu |
| = | 2.87 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Shanghai Rendu |
| = | 1.72 B |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Shanghai Market Capitalization vs Competition
Shanghai Rendu Biotechnology is number one stock in market capitalization category among its peers. Market capitalization of Health Care industry is presently estimated at about 263.35 Billion. Shanghai Rendu maintains roughly 1.72 Billion in market capitalization contributing less than 1% to equities under Health Care industry.
Shanghai Rendu Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Shanghai Rendu, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Shanghai Rendu will eventually generate negative long term returns. The profitability progress is the general direction of Shanghai Rendu's change in net profit over the period of time. It can combine multiple indicators of Shanghai Rendu, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 8.3 M | 8.7 M | |
| Interest Income | 8.7 M | 9.2 M | |
| Operating Income | -8.3 M | -7.9 M | |
| Net Income From Continuing Ops | 8.3 M | 7.8 M | |
| Income Before Tax | 4.8 M | 4.5 M | |
| Net Income | 8.3 M | 7.8 M |
Shanghai Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Shanghai Rendu. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Shanghai Rendu position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Shanghai Rendu's important profitability drivers and their relationship over time.
Use Shanghai Rendu in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Shanghai Rendu position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shanghai Rendu will appreciate offsetting losses from the drop in the long position's value.Shanghai Rendu Pair Trading
Shanghai Rendu Biotechnology Pair Trading Analysis
The ability to find closely correlated positions to Shanghai Rendu could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Shanghai Rendu when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Shanghai Rendu - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Shanghai Rendu Biotechnology to buy it.
The correlation of Shanghai Rendu is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Shanghai Rendu moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Shanghai Rendu Biote moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Shanghai Rendu can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Shanghai Rendu position
In addition to having Shanghai Rendu in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Chemicals Thematic Idea Now
Chemicals
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Chemicals theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Chemicals Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Shanghai Stock
To fully project Shanghai Rendu's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Shanghai Rendu Biote at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Shanghai Rendu's income statement, its balance sheet, and the statement of cash flows.